Role of miR-146b-5p in hyperoxia-induced pulmonary vascular remodeling in neonatal rats: mechanisms based on the regulation of ferroptosis

Wei WANG, Ting ZHAO, Yan-Mei WANG, Ou XIE, Le WANG

Chinese Journal of Contemporary Pediatrics ›› 2026, Vol. 28 ›› Issue (7) : 885-892.

PDF(4440 KB)
HTML
PDF(4440 KB)
HTML
Chinese Journal of Contemporary Pediatrics ›› 2026, Vol. 28 ›› Issue (7) : 885-892. DOI: 10.7499/j.issn.1008-8830.2512010
EXPERIMENTAL RESEARCH

Role of miR-146b-5p in hyperoxia-induced pulmonary vascular remodeling in neonatal rats: mechanisms based on the regulation of ferroptosis

Author information +
History +

Abstract

Objective To investigate the role and mechanism of miR-146b-5p in pulmonary vascular remodeling in neonatal rats with bronchopulmonary dysplasia-associated pulmonary hypertension (BPD-PH) induced by hyperoxia. Methods Thirty-two Sprague-Dawley neonatal rats were randomly assigned to normoxia group, BPD-PH group, overexpression group, and inhibitor group (n=8 per group). The normoxia group was raised in 21% oxygen, while the other groups were exposed to 85.0%±0.5% hyperoxia to induce BPD-PH. The overexpression group received tail vein injection of ADV1-miR-146b-5p adenovirus; the inhibitor group received miR-146b-5p inhibitor injections. After 14 days, adenovirus transfection efficiency in lung tissue was confirmed by confocal microscopy. Right ventricular systolic pressure (RVSP) was measured by direct manometry. Right ventricular hypertrophy index (RVHI) was calculated by weighing isolated ventricular tissues. Hematoxylin-eosin staining was used to assess pulmonary vascular morphology, and medial thickness percentage (MT%) and medial area percentage (MA%) of pulmonary vessels were calculated. Mitochondrial ultrastructure of pulmonary vascular endothelial cells was observed by transmission electron microscopy (TEM). Iron deposition in lung tissue was detected by DAB Prussian blue staining and ferrous ion colorimetric assay. Quantitative real-time PCR was used to measure mRNA expression levels of nuclear factor erythroid 2-related factor 2 (Nrf2), glutathione peroxidase 4 (GPX4), solute carrier family 7 member 11 (SLC7A11), and acyl-CoA synthetase long-chain family member 4 (ACSL4). Protein expression levels of these molecules were detected by Western blotting. Results Compared with the normoxia group, the BPD-PH group showed significantly increased RVSP, RVHI, MT%, and MA% (P<0.05), swollen mitochondria, increased iron deposition, downregulated mRNA and protein expression of Nrf2, GPX4, and SLC7A11, and upregulated expression of ACSL4 (P<0.05). Compared with the BPD-PH group, the overexpression group exhibited further increases in RVSP, RVHI, MT%, and MA%, severe mitochondrial swelling, significantly elevated iron deposition, decreased Nrf2, GPX4, and SLC7A11 mRNA and protein levels, and increased ACSL4 expression (P<0.05). In contrast, the inhibitor group demonstrated decreased RVSP, RVHI, MT%, and MA%, alleviated mitochondrial swelling, reduced iron deposition, upregulated mRNA and protein levels of Nrf2, GPX4, and SLC7A11, and downregulated mRNA and protein levels of ACSL4 (P<0.05). Conclusions Overexpression of miR-146b-5p promotes pulmonary vascular remodeling in neonatal rats exposed to hyperoxia, likely through inhibition of the Nrf2/GPX4 signaling pathway and regulation of ferroptosis.

Key words

Bronchopulmonary dysplasia-associated pulmonary hypertension / miR-146b-5p / Pulmonary vascular remodeling / Ferroptosis / Neonatal rat

Cite this article

Download Citations
Wei WANG , Ting ZHAO , Yan-Mei WANG , et al . Role of miR-146b-5p in hyperoxia-induced pulmonary vascular remodeling in neonatal rats: mechanisms based on the regulation of ferroptosis[J]. Chinese Journal of Contemporary Pediatrics. 2026, 28(7): 885-892 https://doi.org/10.7499/j.issn.1008-8830.2512010

References

[1]
Mascarenhas D, Al-Balushi M, Al-Sabahi A, et al. Pulmonary hypertension in preterm neonates with bronchopulmonary dysplasia: a meta-analysis[J]. Arch Dis Child Fetal Neonatal Ed, 2025, 110(4): 344-352. DOI: 10.1136/archdischild-2024-327547 .
[2]
Li B, Qu SS, Li LX, et al. Risk factors and clinical outcomes of pulmonary hypertension associated with bronchopulmonary dysplasia in extremely premature infants: a systematic review and meta-analysis[J]. Pediatr Pulmonol, 2024, 59(12): 3117-3129. DOI: 10.1002/ppul.27220 .
[3]
王陈红, 陈军津, 葛佳静, 等. 早产儿早期肺动脉高压的危险因素及近期预后[J]. 中华儿科杂志, 2022, 60(7): 682-687. DOI: 10.3760/cma.j.cn112140-20211222-01068 .
[4]
周应祯, 王婷, 付星梦, 等. 支气管肺发育不良的预后[J]. 中国当代儿科杂志, 2025, 27(1): 115-120. PMCID: PMC11750241. DOI: 10.7499/j.issn.1008-8830.2406004 .
[5]
Jia Z, Wang S, Yan H, et al. Pulmonary vascular remodeling in pulmonary hypertension[J]. J Pers Med, 2023, 13(2): 366. PMCID: PMC9967990. DOI: 10.3390/jpm13020366 .
[6]
梁若冰, 朱巧棉, 刘建萍, 等. 早产儿支气管肺发育不良相关肺动脉高压治疗进展[J]. 国际儿科学杂志, 2023, 50(3): 154-158. DOI: 10.3760/cma.j.issn.1673-4408.2023.03.003 .
[7]
Bofill-De Ros X, Vang Ørom UA. Recent progress in miRNA biogenesis and decay[J]. RNA Biol, 2024, 21(1): 1-8. PMCID: PMC10761092. DOI: 10.1080/15476286.2023.2288741 .
[8]
Long Y, Luo Y, Hu L, et al. Targeting miR-146b-5p to regulate KDM6B expression aggravates bronchopulmonary dysplasia[J]. Mol Biotechnol, 2024, 66(8): 2078-2086. DOI: 10.1007/s12033-023-00849-1 .
[9]
Chou HC, Chen CM. Hyperoxia induces ferroptosis and impairs lung development in neonatal mice[J]. Antioxidants (Basel), 2022, 11(4): 641. PMCID: PMC9032171. DOI: 10.3390/antiox11040641 .
[10]
Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease[J]. Nat Rev Mol Cell Biol, 2021, 22(4): 266-282. PMCID: PMC8142022. DOI: 10.1038/s41580-020-00324-8 .
[11]
Luo Y, Zhang Z, Xi S, et al. Bioinformatics analyses and experimental validation of ferroptosis-related genes in bronchopulmonary dysplasia pathogenesis[J]. PLoS One, 2024, 19(6): e0291583. PMCID: PMC11178182. DOI: 10.1371/journal.pone.0291583 .
[12]
Fang C, Tu H, Li R, et al. Bronchopulmonary dysplasia: analysis and validation of ferroptosis-related diagnostic biomarkers and immune cell infiltration features[J]. Pediatr Res, 2024, 96(7): 1673-1680. DOI: 10.1038/s41390-024-03249-6 .
[13]
Zhang F, Liu H. Identification of ferroptosis-associated genes exhibiting altered expression in pulmonary arterial hypertension[J]. Math Biosci Eng, 2021, 18(6): 7619-7630. DOI: 10.3934/mbe.2021377 .
[14]
Li X, Zhang W, Xiao M, et al. MicroRNA-146b-5p protects oligodendrocyte precursor cells from oxygen/glucose deprivation-induced injury through regulating Keap1/Nrf2 signaling via targeting bromodomain-containing protein 4[J]. Biochem Biophys Res Commun, 2019, 513(4): 875-882. DOI: 10.1016/j.bbrc.2019.04.045 .
[15]
Yang M, Chen Y, Huang X, et al. ETS1 ameliorates hyperoxia-induced bronchopulmonary dysplasia in mice by activating Nrf2/HO-1 mediated ferroptosis[J]. Lung, 2023, 201(4): 425-441. PMCID: PMC10444662. DOI: 10.1007/s00408-023-00639-1 .
[16]
谢鸥, 李珊珊, 罗洋, 等. 2-甲氧基雌二醇对新生大鼠缺氧性肺动脉高压的保护作用[J]. 中国当代儿科杂志, 2024, 26(7): 757-764. PMCID: PMC11562046. DOI: 10.7499/j.issn.1008-8830.2401078 .
[17]
谢鸥, 李珊珊, 罗洋, 等. HIF-1α调控TRPC6在新生大鼠HPH肺血管重塑中的作用机制研究[J]. 新疆医科大学学报, 2025, 48(7): 918-923. DOI: 10.3969/j.issn.1009-5551.2025.07.007 .
[18]
Dillon K, Lamba V, Philip RR, et al. Efficacy of sildenafil in infants with bronchopulmonary dysplasia-associated pulmonary hypertension[J]. Children (Basel), 2023, 10(8): 1397. PMCID: PMC10453183. DOI: 10.3390/children10081397 .
[19]
Siddaiah R, Oji-Mmuo C, Aluquin VPR, et al. Multiomics endotyping of preterm infants with bronchopulmonary dysplasia and pulmonary hypertension: a pilot study[J]. Pulm Circ, 2023, 13(2): e12232. PMCID: PMC10142061. DOI: 10.1002/pul2.12232 .
[20]
Song X, Hao X, Zhu BT. Role of mitochondrial reactive oxygen species in chemically-induced ferroptosis[J]. Free Radic Biol Med, 2024, 223: 473-492. DOI: 10.1016/j.freeradbiomed.2024.07.006 .
[21]
Chen D, Yin F, Yang P, et al. TXNIP mediates ferroptosis in a bronchopulmonary dysplasia mouse model by regulating the SLC7A11/GPX4 pathway[J]. Sci Rep, 2025, 15(1): 35188. PMCID: PMC12508065. DOI: 10.1038/s41598-025-19092-6 .
[22]
Ruan Q, Peng Y, Yi X, et al. The tryptophan metabolite 3-hydroxyanthranilic acid alleviates hyperoxia-induced bronchopulmonary dysplasia via inhibiting ferroptosis[J]. Redox Biol, 2025, 82: 103579. PMCID: PMC11981817. DOI: 10.1016/j.redox.2025.103579 .
[23]
Lan J, Chen X, Xu F, et al. Self-assembled miR-134-5p inhibitor nanoparticles ameliorate experimental bronchopulmonary dysplasia (BPD) via suppressing ferroptosis[J]. Mikrochim Acta, 2023, 190(12): 491. PMCID: PMC10687138. DOI: 10.1007/s00604-023-06069-3 .

Footnotes

所有作者声明不存在利益冲突。

PDF(4440 KB)
HTML

Accesses

Citation

Detail

Sections
Recommended

/